Table 3 Worst haematologic CTC toxicity grade per patient

From: A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours

 

80 mg m−2 (no. of patients)

120 mg m−2 (no. of patients)

Anaemia

 1

2

0

 2

2

2

Thrombocytopenia

 1

1

1

 2

0

0

Leukopenia

  

 1

2

1

 2

0

0

Granulocytopenia

  

 1

2

0

 2

0

0

Back to article page